Cargando…

Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma

BACKGROUND: Circulating plasma Epstein Barr Virus DNA (EBV-DNA) is a sensitive and specific marker of nasopharyngeal carcinoma (NPC). The mainstay of treatment of metastatic NPC is systemic chemotherapy and resection for solitary metastasis. Despite high response rate to chemotherapy, complete remis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Stephen L, Hui, Edwin P, Leung, Sing F, Chan, Anthony TC, Ma, Brigette BY
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634867/ https://www.ncbi.nlm.nih.gov/pubmed/17076893 http://dx.doi.org/10.1186/1471-2407-6-259

Ejemplares similares

Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma
por: Ma, Brigette, et al.
Publicado: (2018)

Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma
por: Wong, Chi-Hang, et al.
Publicado: (2018)

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab
por: Wang, Wei Cen, et al.
Publicado: (2023)

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review
por: Prawira, A, et al.
Publicado: (2017)

Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer
por: Tsao, Anne, et al.
Publicado: (2013)

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma
por: Lee, Victor H.F., et al.
Publicado: (2017)

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
por: Ma, Brigette B.Y., et al.
Publicado: (2009)

Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
por: Lam, W. K. Jacky, et al.
Publicado: (2018)

Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Hong, Shaodong, et al.
Publicado: (2016)

Complete small bowel obstruction caused by metastasis from primary nasopharyngeal carcinoma
por: Lau, Chi Pan, et al.
Publicado: (2009)

Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer
por: Loong, Herbert H., et al.
Publicado: (2009)

Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data
por: Li, Leung, et al.
Publicado: (2017)

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Peng, Pei-Jian, et al.
Publicado: (2015)

Prognostic value of early radiological response to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma
por: Liu, Guo‐Ying, et al.
Publicado: (2019)

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
por: Alam, Walid, et al.
Publicado: (2021)

Complete remission in metastatic hepatocellular carcinoma
por: Ben Kridis, Wala, et al.
Publicado: (2023)

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
por: Huang, Luo, et al.
Publicado: (2020)

Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
por: Chan, Sik-Kwan, et al.
Publicado: (2020)

Unknown primary nasopharyngeal melanoma presenting as severe recurrent epistaxis and hearing loss following treatment and remission of metastatic disease: A case report and literature review()
por: Azoury, Saïd C., et al.
Publicado: (2015)

Differential Expression of Long Noncoding RNA in Primary and Recurrent Nasopharyngeal Carcinoma
por: Gao, Wei, et al.
Publicado: (2014)

Nasopharyngeal Carcinoma Metastatic to the Mandible
por: Huang, Po Hsien, et al.
Publicado: (2010)

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
por: Chia, Whay-Kuang, et al.
Publicado: (2014)

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial
por: Chiang, Chi Leung, et al.
Publicado: (2023)

Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.
por: Gebbia, V., et al.
Publicado: (1993)

JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
por: Tan, Laura Ling Ying, et al.
Publicado: (2021)

Sunitinib Enables a Clinical and Pathological Complete Remission of Metastatic Renal Cell Carcinoma (mRCC)
por: Peng, Bo, et al.
Publicado: (2017)

Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
por: Chan, K.C. Allen
Publicado: (2014)

An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma
por: Chan, Sik-Kwan, et al.
Publicado: (2022)

Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
por: Alshamsan, Bader, et al.
Publicado: (2022)

Nasopharyngeal Cancer in Kenya: Radiological Appearances
por: Whittaker, L. R.
Publicado: (1964)

Clinical value of a plasma Epstein–Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis
por: Peng, Haiqin, et al.
Publicado: (2019)

Neoantigen landscape in metastatic nasopharyngeal carcinoma
por: Lin, Mei, et al.
Publicado: (2021)

Prognostic factors in metastatic nasopharyngeal carcinoma
por: Toumi, Nabil, et al.
Publicado: (2020)

Whole-Genome Shotgun Sequencing for Nasopharyngeal Microbiome in Pre-school Children With Recurrent Wheezing
por: Song, Yuping, et al.
Publicado: (2022)

Molecular Targeted Therapy in the Management of Recurrent and Metastatic Nasopharyngeal Carcinoma: A Comprehensive Literature Review
por: Almobarak, Abdulaziz A, et al.
Publicado: (2019)

Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Jin, Ting, et al.
Publicado: (2020)

Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review
por: Yan, Le, et al.
Publicado: (2023)

Radiologic-Pathologic Correlation: Metastatic Pulmonary Epithelioid Hemangioendothelioma of Bone Primary
por: Lee, Christine U, et al.
Publicado: (2015)

Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
por: Tan, Rong, et al.
Publicado: (2020)

Recommendations for surgical management of recurrent nasopharyngeal carcinoma during COVID‐19 pandemic
por: Chow, Velda Ling Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ib392mlolhi2gbn8ts1vuu2rvo